课题基金 / 基金详情

Molecular mechanism underlying cAMP-induced amplification of IGF mitogenic activity through PI3-kinase binding protein, PI3KAP/XB130.

Molecular mechanism underlying cAMP-induced amplification of IGF mitogenic activity through PI3-kinase binding protein, PI3KAP/XB130.
cAMP 通过 PI3 激酶结合蛋白 PI3KAP/XB130 诱导 IGF 有丝分裂活性放大的分子机制。
批准号:
21580345
负责人:
HAKUNO Fumihiko
金额:
$3.16万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

HAKUNO Fumihiko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We previously demonstrated that long-term pretreatment of rat FRTL-5 thyroid cells with TSH or cAMP-generating reagents potentiated IGF-I-dependent DNA synthesis. Under this condition, cAMP treatment increased tyrosine phosphorylation of a 125 kDa protein(p125) and its association with a p85 regulatory subunit of phosphatidylinositol 3-kinase(p85 PI3K), which were suggested to be important for potentiation of DNA synthesis. This study was undertaken to identify p125 and to elucidate its roles in potentiation of DNA synthesis induced by IGF-I. Immunoprecipitated phosphotyrosyl p125 in cAMP-stimulated FRTL-5 cells, was shown by MALDI-TOF MS analysis, to be a rat orthologue of human XB130, which we named phosphatidylinositol 3-kinase-associated protein(PI3KAP). cAMP treatment elevated PI3KAP/XB130 mRNA and protein levels as well as tyrosine phosphorylation and PI3KAP/XB130 interaction with p85 PI3K, leading to increased PI3K activities. Importantly, PI3KAP/XB130 knockdown in FRTL-5 cells attenuated cAMP-dependent potentiation of IGF-I-induced DNA synthesis. Addition of Src family kinase inhibitors, PP1 or PP2, during cAMP treatment abolished tyrosine phosphorylation of PI3KAP/XB130 and its interaction with p85 PI3K. In addition, c-Src was associated with PI3KAP/XB130 and was activated in response to cAMP. Together, these data indicate that cAMP-dependent induction of PI3KAP/XB130 and its association with PI3K are required for enhancement of IGF mitogenic activities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.cub.2011.03.029
发表时间: 2011-04
期刊: Current Biology
影响因子: 9.2
作者: [Yohei Yoshihama;K. Sasaki;Yosuke Horikoshi;A. Suzuki;T. Ohtsuka;F. Hakuno;Shin-ichiro Takahashi;]
通讯作者: Yohei Yoshihama;K. Sasaki;Yosuke Horikoshi;A. Suzuki;T. Ohtsuka;F. Hakuno;Shin-ichiro Takahashi;
GH or IGF-I represses 11beta-hydroxysteroid dehydrogenase type 1(HSD1)mRNA expression in 3T3-L1 and its activity in their homogenates.
GH 或 IGF-I 抑制 3T3-L1 中 11β-羟基类固醇脱氢酶 1 型 (HSD1) mRNA 表达及其匀浆中的活性。
DOI: --
发表时间: 2009
期刊: Endocrine Journal 56
影响因子: --
作者: [Morita J, Hakuno F, Hizuka N, Takahashi SI, Takano K]
通讯作者: Takano K
DOI: 10.3164/jcbn.09-97
发表时间: 2010-03-01
期刊: JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION
影响因子: 2.4
作者: [Kimura, Kumi, Katsumata, Yoshihito, Takenaka, Asako]
通讯作者: Takenaka, Asako
DOI: 10.1677/jme-10-0102
发表时间: 2010-11-01
期刊: JOURNAL OF MOLECULAR ENDOCRINOLOGY
影响因子: 3.5
作者: [Toyoshima, Yuka, Tokita, Reiko, Takahashi, Shin-Ichiro]
通讯作者: Takahashi, Shin-Ichiro
20
    Clearance of insulin resistance by inhibiting diacylglycerol kinaseζ activity
    • 批准号:
      19580324
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2007
    • 负责人:
      HAKUNO Fumihiko
    • 依托单位:
    海外基金